Guy A. Schiehser

1.2k total citations
23 papers, 675 citations indexed

About

Guy A. Schiehser is a scholar working on Molecular Biology, Organic Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Guy A. Schiehser has authored 23 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Guy A. Schiehser's work include Malaria Research and Control (6 papers), Computational Drug Discovery Methods (5 papers) and Antimicrobial Peptides and Activities (5 papers). Guy A. Schiehser is often cited by papers focused on Malaria Research and Control (6 papers), Computational Drug Discovery Methods (5 papers) and Antimicrobial Peptides and Activities (5 papers). Guy A. Schiehser collaborates with scholars based in United States, United Kingdom and Canada. Guy A. Schiehser's co-authors include David P. Jacobus, William R. Jacobs, Joel S. Freundlich, James C. Sacchettini, James D. White, David A. Fidock, Mack Kuo, Gülçin Gülten, Feng Wang and Catherine Vilchèze and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Guy A. Schiehser

23 papers receiving 640 citations

Peers

Guy A. Schiehser
Guy A. Schiehser
Citations per year, relative to Guy A. Schiehser Guy A. Schiehser (= 1×) peers Radim Vičík

Countries citing papers authored by Guy A. Schiehser

Since Specialization
Citations

This map shows the geographic impact of Guy A. Schiehser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy A. Schiehser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy A. Schiehser more than expected).

Fields of papers citing papers by Guy A. Schiehser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy A. Schiehser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy A. Schiehser. The network helps show where Guy A. Schiehser may publish in the future.

Co-authorship network of co-authors of Guy A. Schiehser

This figure shows the co-authorship network connecting the top 25 collaborators of Guy A. Schiehser. A scholar is included among the top collaborators of Guy A. Schiehser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy A. Schiehser. Guy A. Schiehser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Birrell, Geoffrey W., Guy A. Schiehser, John Anderson, et al.. (2018). Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, JPC-3210, for Malaria Treatment and Prevention. Antimicrobial Agents and Chemotherapy. 62(4). 7 indexed citations
2.
Anderson, John W., Dimitri Sarantakis, Jacek Terpiński, et al.. (2012). Novel diaryl ureas with efficacy in a mouse model of malaria. Bioorganic & Medicinal Chemistry Letters. 23(4). 1022–1025. 21 indexed citations
3.
Freundlich, Joel S., Feng Wang, Catherine Vilchèze, et al.. (2009). Triclosan Derivatives: Towards Potent Inhibitors of Drug‐Sensitive and Drug‐Resistant Mycobacterium tuberculosis. ChemMedChem. 4(2). 241–248. 121 indexed citations
4.
Mui, Ernest, Guy A. Schiehser, Wilbur K. Milhous, et al.. (2008). Novel Triazine JPC-2067-B Inhibits Toxoplasma gondii In Vitro and In Vivo. PLoS neglected tropical diseases. 2(3). e190–e190. 44 indexed citations
5.
Kozar, Michael P., Kirsten S. Smith, Jason Sousa, et al.. (2007). Role of Specific Cytochrome P450 Isoforms in the Conversion of Phenoxypropoxybiguanide Analogs in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines. Drug Metabolism and Disposition. 36(2). 380–385. 10 indexed citations
6.
Edstein, Michael D., Barbara Kotecka, Arba L. Ager, et al.. (2007). Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate JPC2056 in cynomolgus monkeys using an in vivo in vitro model. Journal of Antimicrobial Chemotherapy. 60(4). 811–818. 12 indexed citations
7.
Freundlich, Joel S., Mack Kuo, John W. Anderson, et al.. (2007). X-ray Structural Analysis of Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase as a Pathway toward the Optimization of Triclosan Antimalarial Efficacy. Journal of Biological Chemistry. 282(35). 25436–25444. 56 indexed citations
8.
Freundlich, Joel S., Min Yu, Edinson Lucumi, et al.. (2006). Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2′-Substituted triclosan derivatives. Bioorganic & Medicinal Chemistry Letters. 16(8). 2163–2169. 47 indexed citations
9.
Mui, Ernest, David P. Jacobus, Wilbur K. Milhous, et al.. (2005). Triazine Inhibits Toxoplasma gondii Tachyzoites In Vitro and In Vivo. Antimicrobial Agents and Chemotherapy. 49(8). 3463–3467. 26 indexed citations
10.
Hunt, Sonia Y., Gabriele Varani, David P. Jacobus, et al.. (2005). Identification of the optimal third generation antifolate against P. falciparum and P. vivax. Molecular and Biochemical Parasitology. 144(2). 198–205. 20 indexed citations
11.
Shearer, Todd, Michael P. Kozar, Michael T. O’Neil, et al.. (2005). In Vitro Metabolism of Phenoxypropoxybiguanide Analogues in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines. Journal of Medicinal Chemistry. 48(8). 2805–2813. 19 indexed citations
12.
Freundlich, Joel S., John W. Anderson, Dimitri Sarantakis, et al.. (2005). Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4′-Substituted triclosan derivatives. Bioorganic & Medicinal Chemistry Letters. 15(23). 5247–5252. 63 indexed citations
13.
Henion, Jack D., et al.. (1994). Analysis of the Energetics of Gas-Phase Immunophilin-Ligand Complexes by Ion Spray Mass Spectrometry. Journal of the American Chemical Society. 116(17). 7487–7493. 49 indexed citations
14.
Kreft, Anthony F., James A. Nelson, JOHN H. MUSSER, et al.. (1993). Structure-activity relationships leading to WAY-121,520, a tris aryl-type, indomethacin-based, phospholipase A2 (PLA2)/leukotriene biosynthesis inhibitor. Inflammation Research. 39(S1). C33–C35. 4 indexed citations
15.
Kreft, Anthony F., Guy A. Schiehser, & Jerauld S. Skotnicki. (1993). Patent Update: Anti-inflammatory Patent Highlights from the Second Half of 1992. 3(5). 513–543. 2 indexed citations
16.
Abou‐Gharbia, Magid, John A. Moyer, Usha Patel, et al.. (1989). Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents. Journal of Medicinal Chemistry. 32(5). 1024–1033. 36 indexed citations
17.
White, James D., et al.. (1989). Structure, Sythesis and Absolute Configuration of Leptosphaerin, a Metabolite of the Marine Ascomycete Leptosphaeria oraemaris.. Tetrahedron. 45(21). 6631–6644. 38 indexed citations
19.
Nielsen, Susan, et al.. (1987). Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity.. PubMed. 13(5). 297–304. 1 indexed citations
20.
Schiehser, Guy A., James D. White, Gayle K. Matsumoto, John O. Pezzanite, & Jon Clardy. (1986). The structure of leptosphaerin. Tetrahedron Letters. 27(46). 5587–5590. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026